Abstract: Compositions and methods for maintaining healthy mobile joints and cartilage in humans and animals are disclosed. The composition comprises glucosamine and chondroitin dispersed in a controlled-release matrix system capable of releasing the glucosamine and chondroitin over a designated time period. In another aspect, the invention provides compositions and methods for maintaining health mobile joints and cartilage in humans and animals without adversely affecting glucose regulation.
Type:
Grant
Filed:
June 9, 2004
Date of Patent:
March 4, 2008
Assignee:
Leiner Health Services, Corp.
Inventors:
Robert A. Kay, Larry K. Thomas, Beuford A. Bogue
Abstract: The present invention is an orally administered pharmaceutical composition that provides for the controlled release of magnesium. The composition has an interactive agent component and a magnesium component which has an enteric coating that controls the release of the magnesium until the composition is in the small intestine or colon. The other component is released in the stomach and is substantially absorbed prior to the release of the magnesium component. Normally, the interactive agent component decreases the absorption of magnesium when the two components are released simultaneously in the gastrointestinal tract.
Abstract: Compositions and methods for maintaining healthy mobile joints and cartilage in humans and animals are disclosed. The composition comprises a glucosamine component dispersed in a controlled-release matrix system capable of releasing the glucosamine over a designated time period. In another aspect, the invention provides compositions and methods for maintaining health mobile joints and cartilage in humans and animals without adversely affecting glucose regulation.
Type:
Application
Filed:
June 9, 2004
Publication date:
November 25, 2004
Applicant:
Leiner Health Services Corp.
Inventors:
Robert A. Kay, Larry K. Thomas, Beuford A. Bogue
Abstract: Compositions and methods of treatment for conditions in humans and animals which have an inflammatory component, are disclosed. The composition comprises a glucosamine component dispersed in a controlled-release matrix system capable of releasing the glucosamine over a designated time period. In another aspect, the invention provides compositions and methods for the treatment of arthritis in humans and animals without adversely effecting glucose regulation.
Type:
Grant
Filed:
August 29, 2000
Date of Patent:
July 27, 2004
Assignee:
Leiner Health Services Corp.
Inventors:
Robert A. Kay, Larry K. Thomas, Beuford A. Bogue